Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8030637 | 1.00 | CA4 (0.52) | CA4CYP3A4TDP1ACHEMAOB | |
| SCHEMBL29635198 | 0.94 | ACHE (0.54) | CA4CYP3A4ACHECA1CA2 | |
| SCHEMBL197286 | 0.94 | ACHE (0.54) | CA4CYP3A4ACHECA1CA2 | |
| 1,3-Dimethoxybenzene SCHEMBL28127772 | 0.92 | CA4 (0.52) | CA4CYP3A4TDP1ACHEMAOB | |
| SCHEMBL5713343 | 0.91 | ACHE (0.52) | CA4CYP3A4ACHECA1CA2 | |
| Phosphine SCHEMBL6466867 | 0.91 | ACHE (0.52) | CA4CYP3A4ACHECA1CA2 | |
| Hydrochloric Acid SCHEMBL5427158 | 0.91 | ACHE (0.52) | CA4CYP3A4ACHECA1CA2 | |
| 1,3-Dimethoxybenzene SCHEMBL28127423 | 0.90 | MAOB (0.50) | CA4CYP3A4TDP1ACHEMAOB | |
| SCHEMBL16487759 | 0.86 | ACHE (0.69) | CA4CYP3A4ACHEMAOBCA1 | |
| SCHEMBL20873235 | 0.86 | ACHE (0.47) | CA4CYP3A4ACHEMAOBCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2880041-B1 | PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS | COUNCIL SCIENT IND RES (IN) | 2018-10-10 | — | — | EP | claimed |
| WO-2004048463-A1 | POLYMERIC COMPOSITIONS RAPIDLY HEATABLE UNDER ELECTROMAGNETIC IRRADIATION, THEIR USES AND PROCESSING METHODS | PARODI FABRIZIO (IT) | 2004-06-10 | — | — | WO | claimed |
| CN-115055207-B | Method for preparing aryl phosphine by reducing aryl phosphine oxide | 清华大学 | 2023-07-21 | — | — | CN | disclosed |
| CN-115055207-A | Method for preparing aryl phosphine by reducing aryl phosphine oxide | 清华大学 | 2022-09-16 | — | — | CN | disclosed |
| US-20210107859-A1 | A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2021-04-15 | — | — | US | disclosed |
| WO-2019193068-A1 | A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2019-10-10 | — | — | WO | disclosed |
| EP-3549927-A1 | A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2019-10-09 | — | — | EP | disclosed |
| EP-2880041-A1 | PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS | Council of Scientific & Industrial Research (IN) | 2015-06-10 | — | — | EP | disclosed |
| WO-2014024212-A1 | PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-02-13 | — | — | WO | disclosed |
| WO-2004048463-A1 | POLYMERIC COMPOSITIONS RAPIDLY HEATABLE UNDER ELECTROMAGNETIC IRRADIATION, THEIR USES AND PROCESSING METHODS | PARODI FABRIZIO (IT) | 2004-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210107859-A1 | A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS | OTC, MCCC2, CPS1 | CA4 104/4885CYP3A4 14/4885TDP1 3868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.